000 | 01832 a2200541 4500 | ||
---|---|---|---|
005 | 20250516093757.0 | ||
264 | 0 | _c20130619 | |
008 | 201306s 0 0 eng d | ||
022 | _a1476-5594 | ||
024 | 7 |
_a10.1038/onc.2012.204 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJin, W | |
245 | 0 | 0 |
_aAML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. _h[electronic resource] |
260 |
_bOncogene _cApr 2013 |
||
300 |
_a1978-87 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aCathepsin G _xgenetics |
650 | 0 | 4 |
_aCell Differentiation _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCore Binding Factor Alpha 2 Subunit _xgenetics |
650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aGene Expression Regulation, Leukemic |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHL-60 Cells |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 |
_aHematopoiesis _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunologic Surveillance |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xgenetics |
650 | 0 | 4 | _aMDS1 and EVI1 Complex Locus Protein |
650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 | _aProto-Oncogenes |
650 | 0 | 4 | _aRUNX1 Translocation Partner 1 Protein |
650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
650 | 0 | 4 |
_aTumor Escape _ximmunology |
700 | 1 | _aWu, K | |
700 | 1 | _aLi, Y-Z | |
700 | 1 | _aYang, W-T | |
700 | 1 | _aZou, B | |
700 | 1 | _aZhang, F | |
700 | 1 | _aZhang, J | |
700 | 1 | _aWang, K-K | |
773 | 0 |
_tOncogene _gvol. 32 _gno. 15 _gp. 1978-87 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2012.204 _zAvailable from publisher's website |
999 |
_c21817246 _d21817246 |